Jeong-Ju Yoo, Ph.D. - Publications

Affiliations: 
2005 University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Home Economics

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Jun J, Gim J, Kim Y, Kim H, Yu SJ, Yeo I, Park J, Yoo JJ, Cho YY, Lee DH, Cho EJ, Lee JH, Kim YJ, Lee S, Yoon JH, et al. Analysis of significant protein abundance from multiple reaction-monitoring data. Bmc Systems Biology. 12: 123. PMID 30598095 DOI: 10.1186/s12918-018-0656-9  0.44
2018 Yoo JJ, Chang Y, Cho EJ, Moon JE, Kim SG, Kim YS, Lee YB, Lee JH, Yu SJ, Kim YJ, Yoon JH. Timing of upper gastrointestinal endoscopy does not influence short-term outcomes in patients with acute variceal bleeding. World Journal of Gastroenterology. 24: 5025-5033. PMID 30510377 DOI: 10.3748/wjg.v24.i44.5025  0.44
2015 Cho Y, Yoon JH, Yoo JJ, Lee M, Lee DH, Cho EJ, Lee JH, Yu SJ, Kim YJ, Kim CY. Fucoidan protects hepatocytes from apoptosis and inhibits invasion of hepatocellular carcinoma by up-regulating p42/44 MAPK-dependent NDRG-1/CAP43. Acta Pharmaceutica Sinica. B. 5: 544-53. PMID 26713269 DOI: 10.1016/j.apsb.2015.09.004  0.44
2015 Cho EJ, Lee JH, Cho Y, Lee YB, Yoo JJ, Lee M, Lee DH, Yu SJ, Kim YJ, Yoon JH, Lee HS. Comparison of the Efficacy of Entecavir and Tenofovir in Nucleos(T)ide Analogue-Experienced Chronic Hepatitis B Patients. Plos One. 10: e0130392. PMID 26121361 DOI: 10.1371/journal.pone.0130392  0.36
2015 Yoo JJ, Cho EJ, Cho YY, Lee M, Lee DH, Cho Y, Lee JH, Yu SJ, Yoon SS, Yoon JH, Kim YJ. Efficacy of antiviral prophylaxis in HBsAg-negative, anti-HBc positive patients undergoing hematopoietic stem cell transplantation. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 26053357 DOI: 10.1111/liv.12882  0.36
2015 Yoo JJ, Lee JH, Yoon JH, Lee M, Lee DH, Cho Y, Jang ES, Cho EJ, Yu SJ, Kim YJ, Lee HS. Hepatitis B virus-related glomerulonephritis: not a predominant cause of proteinuria in korean patients with chronic hepatitis B. Gastroenterology Research and Practice. 2015: 126532. PMID 25788940 DOI: 10.1155/2015/126532  0.36
2015 Choi WM, Lee JH, Ahn H, Cho H, Cho YY, Lee M, Yoo JJ, Cho Y, Lee DH, Lee YB, Cho EJ, Yu SJ, Yi NJ, Lee KW, Kim YJ, et al. Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 25556714 DOI: 10.1111/liv.12776  0.36
2015 Lee YB, Jung EU, Kim BH, Lee JH, Cho H, Ahn H, Choi WM, Cho YY, Lee M, Yoo JJ, Cho Y, Lee DH, Cho EJ, Yu SJ, Park SJ, et al. Tenofovir monotherapy versus tenofovir plus lamivudine or telbivudine combination therapy in treatment of lamivudine-resistant chronic hepatitis B. Antimicrobial Agents and Chemotherapy. 59: 972-8. PMID 25421484 DOI: 10.1128/AAC.04454-14  0.36
2015 Lee M, Lee JH, Oh S, Jang Y, Lee W, Lee HJ, Yoo JJ, Choi WM, Cho YY, Cho Y, Lee DH, Lee YB, Yu SJ, Yi NJ, Lee KW, et al. CLIF-SOFA scoring system accurately predicts short-term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis. Liver International : Official Journal of the International Association For the Study of the Liver. 35: 46-57. PMID 25203221 DOI: 10.1111/liv.12683  0.44
2014 Yoo JJ, Lee JH, Lee SH, Lee M, Lee DH, Cho Y, Lee YB, Yu SJ, Kim HC, Kim YJ, Yoon JH, Kim CY, Lee HS. Comparison of the effects of transarterial chemoembolization for advanced hepatocellular carcinoma between patients with and without extrahepatic metastases. Plos One. 9: e113926. PMID 25427152 DOI: 10.1371/journal.pone.0113926  0.44
2014 Lee YB, Lee JH, Lee DH, Cho H, Ahn H, Choi WM, Cho YY, Lee M, Yoo JJ, Cho Y, Cho EJ, Yu SJ, Kim YJ, Yoon JH, Kim CY, et al. Efficacy of entecavir-tenofovir combination therapy for chronic hepatitis B patients with multidrug-resistant strains. Antimicrobial Agents and Chemotherapy. 58: 6710-6. PMID 25155601 DOI: 10.1128/AAC.03845-14  0.36
2014 Cho Y, Lee DH, Lee YB, Lee M, Yoo JJ, Choi WM, Cho YY, Paeng JC, Kang KW, Chung JK, Yu SJ, Lee JH, Yoon JH, Lee HS, Kim YJ. Does 18F-FDG positron emission tomography-computed tomography have a role in initial staging of hepatocellular carcinoma? Plos One. 9: e105679. PMID 25153834 DOI: 10.1371/journal.pone.0105679  0.44
2014 Cho E, Kim HC, Lee JH, Jeong-Ju Yoo, Choi WM, Cho YY, Lee MJ, Cho Y, Lee DH, Lee YB, Yu SJ, Kim YJ, Yoon JH, Chung JW, Kim CY, et al. Serum insulin-like growth factor-1 predicts disease progression and survival in patients with hepatocellular carcinoma who undergo transarterial chemoembolization. Plos One. 9: e90862. PMID 24595361 DOI: 10.1371/journal.pone.0090862  0.44
2014 Lee JH, Cho Y, Lee DH, Lee M, Yoo JJ, Choi WM, Cho YY, Lee YB, Yu SJ, Yoon JH, Lee HS, Kim YJ. Prior exposure to lamivudine increases entecavir resistance risk in chronic hepatitis B Patients without detectable lamivudine resistance. Antimicrobial Agents and Chemotherapy. 58: 1730-7. PMID 24395227 DOI: 10.1128/AAC.02483-13  0.44
2014 Cho Y, Park SY, Lee JH, Lee DH, Lee M, Yoo JJ, Choi WM, Cho YY, Lee YB, Yoon JW, Kwon JH, Cho EJ, Yu SJ, Kim YJ, Yoon JH, et al. High-sensitivity C-reactive protein level is an independent predictor of poor prognosis in cirrhotic patients with spontaneous bacterial peritonitis. Journal of Clinical Gastroenterology. 48: 444-9. PMID 24045283 DOI: 10.1097/MCG.0b013e3182a6cdef  0.36
2013 Lee YB, Lee JH, Choi WM, Cho YY, Yoo JJ, Lee M, Lee DH, Cho Y, Yu SJ, Kim YJ, Yoon JH, Kim CY, Lee HS. Efficacy of adefovir-based combination therapy for patients with Lamivudine- and entecavir-resistant chronic hepatitis B virus infection. Antimicrobial Agents and Chemotherapy. 57: 6325-32. PMID 24100506 DOI: 10.1128/AAC.01742-13  0.44
2013 Cho EJ, Lee JH, Yoo JJ, Choi WM, Lee MJ, Cho Y, Lee DH, Lee YB, Kwon JH, Yu SJ, Lee JM, Suh KS, Kim K, Kim YJ, Yoon JH, et al. Serum insulin-like growth factor-I level is an independent predictor of recurrence and survival in early hepatocellular carcinoma: a prospective cohort study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4218-27. PMID 23757355 DOI: 10.1158/1078-0432.CCR-12-3443  0.36
Show low-probability matches.